Daewoong wins world's first EPO material halal certification
Daewoong wins world's first EPO material halal certification
  • Jung Jun-ho
  • 승인 2020.01.07 11:32
  • 댓글 0
이 기사를 공유합니다

Source=Daewoong Pharmaceutical

Daewoong Infion has become the first in the world to win halal certification for bio drugs derived from animal cells.

Daewoong Pharmaceutical said on Jan. 6 that its Indonesian joint venture, Daewoong Infion, has won halal certification for epodion, an "erythropoietin" material, or EPO, from the Indonesian halal certification agency. (LPPOM MUI)

Daewoong Infion is a joint venture established by Daewoong Pharmaceutical in 2012 with Indonesian firm Infion. It has completed construction of Indonesia’s first bio-medicine plant in Surabaya and is the first local manufacturer to produce and sell biosimilar drug epodion.

Epodion is anemic treatment for chronic renal failure and anti-cancer patients such as kidney dialysis. It obtained a sales license from the Indonesian Ministry of Food and Drug Administration in December 2016 and was released in the Indonesian market in April 2017.

Six months after its release, it has topped the market share of the Indonesian EPO. It currently holds more than 40 percent of the market.

The world's Muslim population is estimated to be around 1.8 billion. The number is expected to reach about 3 billion by 2060.

Following the momentum, Daewoong Infion plans to win halal certification for all products it produces in Indonesia, including Epidermal Growth Factor (EGF), and growth hormone-based Caretropin.

"We will push to enter the Middle East drug market worth 80 trillion won based on halal certification in Indonesia, the largest country in Islam," said CEO Seo Chang-woo of Daewoong Infion.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: www.koreaittimes.com / m.koreaittimes.com. Editorial Div. 02-578-0434 / 010-2442-9446. Email: info@koreaittimes.com.
  • Publisher: Monica Younsoo Chung. CEO: Lee Kap-soo. Editor: Jung Yeon-jin. Juvenile Protection Manager: Yeon Choul-woong.
  • IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.
ND소프트